ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
May 10, 2016
Big Pharma 1Q Earnings Roundup, Part I
Image Source: Rodrigo. Let’s take a look at the performance of some of the biggest pharmaceutical companies on the market today. In this article: AZN, ABT, BIIB, LLY, GSK, VRTX, ZTS.
May 9, 2016
Dividend Increases/Decreases for the Week Ending May 6
Let's take a look at companies raising/lowering their dividends this week.
Apr 25, 2016
Iron Ore Market Stability Still A Ways Off
Image Source: Peter Craven. Despite some recent positive headlines and a relatively small rally in iron ore prices, the iron ore market may still be a long way from correcting the current supply glut. Let’s take a look at what’s going on at some the world’s largest producers in an attempt to get to the bottom of things.
Apr 21, 2016
The Market – On Its Head
Let’s discuss what’s been working and what’s not been working in today’s market.
Apr 12, 2016
Alcoa Continues Swoon, Revises Aerospace 2016 Outlook to 6%-8% Expansion
Image Source: Alcoa. The lack of an investment case in Alcoa remains, but there are other ideas in the commercial aerospace supply chain to consider, even as the current upswing in deliveries tires.
Mar 10, 2016
Part I: Nelson’s Evaluation of Berkshire’s 2015 Annual Report
Image Source: Fortune Live Media. The first of Nelson’s three-part evaluation of Berkshire Hathaway’s 2015 annual report.
Feb 22, 2016
Key Treatment Momentum Drives Big Pharma
Let’s take a look at the recent results of some of the biggest names in Big Pharma.
Feb 17, 2016
Feb 8, 2016
Market’s Swooning: Bye Bye Energy MLPs, Part II
The broader equity markets remain a very difficult environment.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.